Free Trial

Rapid Micro Biosystems (RPID) Competitors

Rapid Micro Biosystems logo
$2.72 +0.28 (+11.48%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$2.72 -0.01 (-0.18%)
As of 09/5/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPID vs. LAB, SENS, FEIM, MASS, QSI, QTRX, KEQU, OWLT, SEER, and PRE

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), 908 Devices (MASS), Quantum-Si (QSI), Quanterix (QTRX), Kewaunee Scientific (KEQU), Owlet (OWLT), Seer (SEER), and Prenetics Global (PRE). These companies are all part of the "measuring and control equipment" industry.

Rapid Micro Biosystems vs. Its Competitors

Standard BioTools (NASDAQ:LAB) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

In the previous week, Standard BioTools had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 5 mentions for Standard BioTools and 3 mentions for Rapid Micro Biosystems. Standard BioTools' average media sentiment score of 1.47 beat Rapid Micro Biosystems' score of 1.27 indicating that Standard BioTools is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Standard BioTools
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rapid Micro Biosystems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Standard BioTools currently has a consensus target price of $1.55, indicating a potential upside of 19.23%. Rapid Micro Biosystems has a consensus target price of $8.00, indicating a potential upside of 194.12%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Standard BioTools
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Rapid Micro Biosystems
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Standard BioTools has a net margin of -69.08% compared to Rapid Micro Biosystems' net margin of -145.63%. Standard BioTools' return on equity of -20.23% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Standard BioTools-69.08% -20.23% -15.32%
Rapid Micro Biosystems -145.63%-63.07%-48.33%

53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 23.2% of Standard BioTools shares are owned by insiders. Comparatively, 30.0% of Rapid Micro Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Standard BioTools has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.

Rapid Micro Biosystems has lower revenue, but higher earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Standard BioTools$174.43M2.85-$138.88M-$0.32-4.06
Rapid Micro Biosystems$28.05M4.29-$46.89M-$1.01-2.69

Summary

Standard BioTools and Rapid Micro Biosystems tied by winning 8 of the 16 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$120.25M$7.02B$5.83B$9.92B
Dividend YieldN/A1.21%6.70%4.52%
P/E Ratio-2.6926.4776.2926.13
Price / Sales4.29144.15529.69172.60
Price / CashN/A22.0236.9959.28
Price / Book1.554.9911.486.09
Net Income-$46.89M$176.38M$3.29B$266.51M
7 Day Performance12.86%-0.03%1.28%0.45%
1 Month Performance-18.81%5.07%8.56%5.05%
1 Year Performance225.75%10.24%61.19%26.03%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPID
Rapid Micro Biosystems
3.7533 of 5 stars
$2.72
+11.5%
$8.00
+194.1%
+225.7%$120.25M$28.05M-2.69200News Coverage
LAB
Standard BioTools
2.6393 of 5 stars
$1.24
-2.4%
$1.55
+25.0%
-33.0%$485.13M$174.43M-3.88620News Coverage
Positive News
Insider Trade
SENS
Senseonics
2.1972 of 5 stars
$0.46
-0.3%
$1.55
+240.1%
+41.9%$372.64M$25.47M-3.5190News Coverage
FEIM
Frequency Electronics
1.9116 of 5 stars
$30.81
+6.2%
N/A+130.0%$282.21M$69.81M12.47200News Coverage
Upcoming Earnings
MASS
908 Devices
3.5608 of 5 stars
$6.27
-2.8%
$8.00
+27.6%
+52.4%$231.30M$65.56M-11.6160News Coverage
Analyst Downgrade
QSI
Quantum-Si
2.5463 of 5 stars
$1.14
flat
$3.48
+204.8%
+18.6%$230.85M$3.06M-1.68150News Coverage
Positive News
QTRX
Quanterix
2.4191 of 5 stars
$4.67
-3.3%
$11.75
+151.6%
-62.1%$224.43M$137.42M-2.57460News Coverage
Positive News
KEQU
Kewaunee Scientific
1.0142 of 5 stars
$56.39
-2.2%
N/A+2.4%$169.96M$240.47M14.721,239News Coverage
Upcoming Earnings
Short Interest ↑
OWLT
Owlet
2.9323 of 5 stars
$7.41
-1.6%
$10.25
+38.3%
+64.2%$128.35M$78.10M-2.12106News Coverage
Analyst Revision
SEER
Seer
0.8891 of 5 stars
$2.10
-0.5%
N/A+28.0%$118.88M$14.17M-1.51160
PRE
Prenetics Global
1.3269 of 5 stars
$7.33
+1.1%
$9.00
+22.8%
+66.5%$94.14M$30.62M-1.841

Related Companies and Tools


This page (NASDAQ:RPID) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners